Open AccessModafinil Enhances Two-Year Outcome from Monoamine Oxidase Inhibitor Therapy in 3 Patients with Treatment-Resistant Depression
Publication year - 2015
Publication title -
advances in pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
ISSN - 2167-1052
DOI - 10.4172/2167-1052.1000189
Subject(s) - modafinil , monoamine oxidase , depression (economics) , medicine , selegiline , pharmacology , treatment resistant depression , monoamine oxidase inhibitor , monoamine oxidase a , moclobemide , bioinformatics , psychiatry , chemistry , major depressive disorder , biology , mood , enzyme , parkinson's disease , biochemistry , anxiety , disease , antidepressant , macroeconomics , economics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom